General Information
Version
3.0.0
Revision date
2017-04-03
Product name
Vidaza powder for suspension for injection; azacitidine for injection
Product Synonyms
Mylosar, Ladakamycin
Chemical name
Mixture - contains pyrimidine nucleoside analog
CAS No.
320-67-2
1.2.1 Relevant identified uses
Bulk formulated pharmaceutical product/ Formulated pharmaceutical product of the substance or packaged in final form for patient use; indicated for the treatment of certain mixture and uses myelodysplastic syndromes
Emergency telephone
+1 (800) 424-9300, +1 (703) 527-3887
Icons in SDS
Company Information
company name
Celgene Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
MSDScoordinator@Celgene.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H341, H350, H360FD, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
H341
Suspected of causing genetic defects
H350
May cause cancer
H360FD
May damage fertility. May damage the unborn child.
H372
Causes damage to organs through prolonged or repeated exposure
H400
Very toxic to aquatic life
H410
Very toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
WHMIS 2015 Classification of the substance or mixture Drugs in the finished state and intended for the final user are not subject to labeling in the US, EU or Canada. Please consult the prescribing/packaging information. The classification and labelling listed below is for bulk Vidaza Globally Harmonized System [GHS] Carcinogenic - Category 1B. Germ Cell Mutagenicity - Category 2. Reproductive Toxicity - Category 1B. Acute toxicity - oral - Category 4. Specific Target Organ Toxicity (repeated exposure) - Category 1. Aquatic toxicity (acute) - Category 1 Aquatic toxicity (chronic) - Category 1 HAZARDS IDENTIFICATION …continued
Signal word
Danger
Hazard statements
H302 - Harmful if swallowed. H341 - Suspected of causing genetic defects. H350 - May cause cancer. H360FD - May damage fertility. May damage the unborn child. H372 - Causes damage to hematological and gastrointestinal systems through prolonged or repeated exposure. H400 - Very toxic to aquatic life. H410 - Very toxic to aquatic life with long-lasting effects. precautions have been read and understood. P260 - Do not breathe dust. P264 - Wash hands thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P273 - Avoid release to the environment. P281 - Use personal protective equipment as required. P308 + P313 - If exposed or concerned: get medical advice/attention. P301+P312 IF SWALLOWED Call a Poison Center or doctor/physician if you feel unwell. P330 - Rinse mouth. P391 - Collect spillage. P405 - Store locked up. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations. P280 - Wear protective gloves/eye protection/face protection. P308 + P313 - IF exposed or concerned: get medical advice/attention.
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety
2.3 Other hazards
The most commonly occurring adverse effects with therapeutic use include hematological toxicity (e.g., thrombocytopenia, anemia, neutropenia), fever, gastrointestinal effects (e.g., nausea, vomiting, diarrhea, constipation), fatigue, injection site erythema, ecchymosis (skin discoloration caused by escape of blood into tissues from ruptured blood vessels). Other effects may include hypotension, shortness of breath, liver/kidney toxicity and electrolyte abnormalities. Post- marketing reports of interstitial lung disease and tumor lysis syndrome may also be azacitidine-related. Note This mixture is classified as hazardous under GHS as implemented by Regulation
2.1 Classification of the substance or mixture
Drugs in the finished state and intended for the final user are not subject to substance or mixture